SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2132445

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132445

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy), By Disease (NAFLD, NASH, Fibrosis), By End Use (Hospitals, Laboratories), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Liver Disease Diagnostics Market Summary

The global liver disease diagnostics market size was valued at USD 40.5 billion in 2025 and is projected to grow from USD 43.2 billion in 2026 to USD 66.4 billion by 2033, at a CAGR of 6.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 43.1% in 2025. The growth is primarily driven by the increasing prevalence of chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma.

The adoption of non-invasive diagnostic technologies, molecular diagnostics, biomarker-based assays, and artificial intelligence-enabled imaging is strengthening early disease detection, improving diagnostic accuracy, and supporting informed clinical decision-making. These advancements, coupled with expanding liver disease screening programs, increasing investments in precision medicine, and continued product innovation by leading market participants, are expected to strengthen diagnostic capabilities and support sustained market growth.

Global Liver Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liver disease diagnostics market report on the basis of diagnosis technique, disease, end-use, and region:

  • Diagnosis Technique Outlook (Revenue, USD Billion, 2021 - 2033)
  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others
  • Disease Outlook (Revenue, USD Billion, 2021 - 2033)
  • NAFLD
  • NASH
  • Fibrosis
  • Cirrhosis
  • HCC
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68038-693-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Diagnosis Technique Segment
    • 1.2.2. Disease Segment
    • 1.2.3. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Liver Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of metabolic and chronic liver diseases
      • 3.2.1.2. Advancements in Diagnostic Technologies
      • 3.2.1.3. Increasing Awareness and Early Detection
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Advanced Diagnostics
      • 3.2.2.2. Limited Awareness in Developing Regions
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Liver Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Liver Disease Diagnostics Market: Diagnosis Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
  • 4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Diagnosis Technique, 2021 to 2033 (USD Billion)
  • 4.4. Imaging
    • 4.4.1. Imaging market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.5. Laboratory Tests
    • 4.5.1. Laboratory Tests market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.6. Endoscopy
    • 4.6.1. Endoscopy market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.7. Biopsy
    • 4.7.1. Biopsy market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 5. Global Liver Disease Diagnostics Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
  • 5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Disease, 2021 to 2033 (USD Billion)
  • 5.4. NAFLD
    • 5.4.1. NAFLD market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.5. NASH
    • 5.5.1. NASH market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.6. Fibrosis
    • 5.6.1. Fibrosis market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.7. Cirrhosis
    • 5.7.1. Cirrhosis market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.8. HCC
    • 5.8.1. HCC market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 6. Global Liver Disease Diagnostics Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Liver Disease Diagnostics Market End-use Movement Analysis
    • 6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.4. Laboratories
    • 6.4.1. Laboratories market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 7. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. List of Key Certification Providers/Scheme Owners
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. F. Hoffmann-La Roche Ltd.
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Thermo Fisher Scientific Inc.
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Randox Laboratories Ltd
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Boston Scientific Corporation
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Laboratory Corporation of America Holdings
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Fujifilm Corporation
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Horiba Medical
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Siemens Healthcare GmbH
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Quest Diagnostics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-693-6

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 U.S. Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 6 North America Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 7 North America Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 8 North America Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 9 North America Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 10 Canada Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 11 Canada Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 12 Canada Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 13 Mexico Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 14 Mexico Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 15 Mexico Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 16 Europe Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 17 Europe Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 18 Europe Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 19 Europe Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 20 UK Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 21 UK Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 22 UK Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 23 Germany Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 24 Germany Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 25 Germany Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 26 France Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 27 France Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 28 France Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 29 Italy Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 30 Italy Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 31 Italy Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 32 Spain Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 33 Spain Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 34 Spain Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 35 Denmark Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 36 Denmark Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 37 Denmark Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 38 Sweden Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 39 Sweden Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 40 Sweden Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 41 Norway Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 42 Norway Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 43 Norway Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 44 Asia Pacific Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 45 Asia Pacific Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 46 Asia Pacific Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 47 Asia Pacific Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 48 Japan Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 49 Japan Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 50 Japan Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 51 China Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 52 China Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 53 China Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 54 India Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 55 India Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 56 India Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 57 Australia Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 58 Australia Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 59 Australia Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 60 South Korea Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 61 South Korea Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 62 South Korea Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 63 Thailand Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 64 Thailand Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 65 Thailand Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 66 Latin America Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 67 Latin America Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 68 Latin America Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 69 Latin America Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 70 Brazil Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 71 Brazil Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 72 Brazil Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 73 Argentina Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 74 Argentina Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 75 Argentina Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 76 MEA Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 77 MEA Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 78 MEA Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 79 MEA Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 80 South Africa Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 81 South Africa Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 82 South Africa Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 83 Saudi Arabia Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 84 Saudi Arabia Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 85 Saudi Arabia Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 86 UAE Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 87 UAE Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 88 Kuwait Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 89 Kuwait Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 90 Kuwait Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Liver disease diagnostics: Market outlook
  • Fig. 9 Liver disease diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Liver disease diagnostics market driver impact
  • Fig. 15 Liver disease diagnostics market restraint impact
  • Fig. 16 Liver disease diagnostics market strategic initiatives analysis
  • Fig. 17 Liver disease diagnostics market: disease movement analysis
  • Fig. 18 Liver disease diagnostics market: disease outlook and key takeaways
  • Fig. 19 NAFLD market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 20 NASH market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 21 Fibrosis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 22 Cirrhosis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 HCC market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 25 Liver disease diagnostics market: Diagnosis technique movement analysis
  • Fig. 26 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
  • Fig. 27 Imaging market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 28 Laboratory tests market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 29 Endoscopy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 30 Biopsy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Liver disease diagnostics market: End use movement analysis
  • Fig. 33 Liver disease diagnostics market: End use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 35 Laboratories market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 Global liver disease diagnostics market: Regional movement analysis
  • Fig. 38 Global liver disease diagnostics market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 40 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 China market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 India market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 65 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!